George Church’s woolly mammoth revival biotech Colossal spins out computational bio outfit
Colossal Biosciences has a somewhat lofty goal — revive the woolly mammoth. When the biotech launched in 2021, its CEO Ben Lamm compared its mission to the Apollo program in an interview with CNN, equating its aspirations to space exploration, but noting that it could make other breakthroughs along the way, as Apollo did with GPS.
Now Colossal is sharing its version of the GPS, an AI platform that is meant to make managing massive datasets — commonplace in biotech today — more user-friendly and less code-heavy.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.